Quoin Pharmaceuticals News

Quoin Pharmaceuticals | 8-K: Current report

Apr 9 16:11 ET

Quoin Pharmaceuticals | EFFECT: Others

Apr 4 06:05 ET

Quoin Pharmaceuticals | DEFA14A: Others

Apr 2 11:09 ET

Quoin Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 29 16:15 ET

Quoin Pharmaceuticals | 10-K: Annual report

Mar 14 16:46 ET

Quoin Pharmaceuticals | 8-K: Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results

Mar 13 16:56 ET

Quoin Pharmaceuticals | 424B3: Prospectus

Mar 8 16:13 ET

Quoin Pharmaceuticals | 8-K: Current report

Mar 8 16:08 ET

Quoin Pharmaceuticals | 424B3: Prospectus

Mar 8 16:06 ET

Quoin Pharmaceuticals | 424B4: Prospectus

Mar 6 17:11 ET

Quoin Pharmaceuticals | 8-K: Current report

Mar 6 16:06 ET

Quoin Pharmaceuticals | 424B3: Prospectus

Mar 4 17:34 ET

Quoin Pharmaceuticals | DEF 14A: Definitive information statements

Feb 27 06:11 ET

Quoin Pharmaceuticals | EFFECT: Others

Feb 15 06:12 ET

Quoin Pharmaceuticals | CORRESP: CORRESP

Feb 14 12:36 ET

Quoin Pharmaceuticals | CORRESP: CORRESP

Feb 14 12:36 ET

Quoin Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(6.0%),Lind Global Partners II LLC(6.0%), etc.

Feb 13 20:16 ET

Quoin Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Feb 13 16:55 ET

Quoin Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Feb 13 16:39 ET

Quoin Pharmaceuticals | UPLOAD: Others

Feb 13 12:36 ET